Involvement of selective alpha-2 adrenoreceptor in sympathetically maintained pain

Area of Science:

• Neurology
• Pain Management
• Pharmacology

Background:

• Peripheral nerve injury frequently causes neuropathic pain, featuring burning sensations, allodynia, and hyperalgesia.
• The sympathetic nervous system's involvement in neuropathic pain is complex, with alpha-1 receptors recognized for their role in sympathetic-mediated pain.

Purpose of the Study:

• To investigate the hypothesis that peripheral alpha-2 adrenoreceptors are implicated in sympathetically maintained pain in humans.
• To evaluate the efficacy of alpha-2 adrenoreceptor antagonists in managing neuropathic pain.

Main Methods:

• A randomized, prospective, double-blinded, crossover study involving twenty patients.
• Patients received infusions of Yohimbine (an alpha-2 antagonist) and Phentolamine (an alpha-1 and alpha-2 antagonist) on separate occasions.
• Pain was assessed using the visual analogue scale, neuropathic pain questionnaire, and McGill pain questionnaire.

Main Results:

• Both Yohimbine and Phentolamine treatments resulted in significant reductions in pain scores across all measurement scales.
• This indicates a substantial role for alpha-2 adrenoreceptors in the studied pain condition.

Conclusions:

• Alpha-2 adrenoreceptors, alongside alpha-1 adrenoreceptors, appear to play a role in sympathetically maintained pain in humans.
• These findings suggest potential therapeutic targets for managing neuropathic pain associated with sympathetic nervous system dysfunction.